NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $38,000 | -15.6% | 500 | -16.7% | 0.01% | -25.0% |
| Q1 2017 | $45,000 | -4.3% | 600 | -6.8% | 0.01% | -14.3% |
| Q4 2016 | $47,000 | -2.1% | 644 | +4.9% | 0.01% | 0.0% |
| Q3 2016 | $48,000 | -5.9% | 614 | 0.0% | 0.01% | -17.6% |
| Q2 2016 | $51,000 | +2.0% | 614 | -11.4% | 0.02% | -15.0% |
| Q1 2016 | $50,000 | +31.6% | 693 | +58.6% | 0.02% | +42.9% |
| Q4 2015 | $38,000 | +18.8% | 437 | +24.9% | 0.01% | +16.7% |
| Q3 2015 | $32,000 | -60.5% | 350 | -57.7% | 0.01% | -57.1% |
| Q2 2015 | $81,000 | +72.3% | 827 | +74.1% | 0.03% | +75.0% |
| Q1 2015 | $47,000 | +6.8% | 475 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $44,000 | -2.2% | 475 | 0.0% | 0.02% | -5.9% |
| Q3 2014 | $45,000 | +1025.0% | 475 | +910.6% | 0.02% | +750.0% |
| Q3 2013 | $4,000 | +33.3% | 47 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $3,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |